Fund II Team
Ian Clements has over 25 years of experience in Senior Sales and Marketing, Medical Affairs, Project Management, Business Development positions in large pharmaceutical companies, including 6 years at Pharmacia Upjohn as head of Global oncology marketing for CAMPTOSAR and 3 years as head of US Oncology Marketing for Novartis, managing their oncology portfolio with over $2B in sales and launching 3 oncology products in his tenure.
Previously, Ian spent 6 years as head of Commercial Operations and Corporate Development for ILEX Oncology where he helped establish the new Business Development and Project Management systems. While at ILEX, he headed departments including, Business Development, Medical Affairs, Partner Relations and Commercial Development.
Drawing on his pharmaceutical background, Ian co-founded and currently manages two life science companies from the Targeted Technology Fund I portfolio: ViroXis Corporation and Santalis Pharmaceuticals. Ian has a B.Sc. Honors in Genetics from Swansea University (Wales) and M.Sc. in Immunology from King’s College London.